Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Safety was equally impressive. ENV-294 was well tolerated
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Subscribe To Our Newsletter & Stay Updated